{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:56:14Z","timestamp":1793084174867,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["No.2021YFC2700700"],"award-info":[{"award-number":["No.2021YFC2700700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10067-022-06496-2","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T02:03:34Z","timestamp":1675303414000},"page":"1223-1235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-6754","authenticated-orcid":false,"given":"Yingnan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0708-0237","authenticated-orcid":false,"given":"Yumei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-4395","authenticated-orcid":false,"given":"Yueyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-2102","authenticated-orcid":false,"given":"Huixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"6496_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/s0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet (London, England) 376:631\u2013644. https:\/\/doi.org\/10.1016\/s0140-6736(10)60279-6","journal-title":"Lancet (London, England)"},{"key":"6496_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1095\/biolreprod.112.102723","volume":"87","author":"R Tal","year":"2012","unstructured":"Tal R (2012) The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 87:134. https:\/\/doi.org\/10.1095\/biolreprod.112.102723","journal-title":"Biol Reprod"},{"key":"6496_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testamSkorpen","year":"2016","unstructured":"G\u00f6testamSkorpen C, Hoeltzenbein M, Tincani A et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75:795\u2013810. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208840","journal-title":"Ann Rheum Dis"},{"key":"6496_CR4","first-page":"10","volume":"21","author":"L Zhou","year":"2017","unstructured":"Zhou L, Xin X, Chu Y (2017) The efficacy and safety of hydroxychloroquine sulfate on pregnancy outcomes in patients with systemic lupus erythematosus. Chin J Rheumatol 21:10\u201314","journal-title":"Chin J Rheumatol"},{"key":"6496_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(02)07643-2","volume":"359","author":"M Motta","year":"2002","unstructured":"Motta M, Tincani A, Faden D, Zinzini E, Chirico G (2002) Antimalarial agents in pregnancy. Lancet 359:524\u2013525. https:\/\/doi.org\/10.1016\/S0140-6736(02)07643-2","journal-title":"Lancet"},{"key":"6496_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","volume":"23","author":"KD Rainsford","year":"2015","unstructured":"Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF (2015) Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 23:231\u2013269. https:\/\/doi.org\/10.1007\/s10787-015-0239-y","journal-title":"Inflammopharmacology"},{"key":"6496_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0961203319843343","volume":"28","author":"MR Seo","year":"2019","unstructured":"Seo MR, Chae J, Kim YM et al (2019) Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia. Lupus 28:722\u2013730. https:\/\/doi.org\/10.1177\/0961203319843343","journal-title":"Lupus"},{"key":"6496_CR8","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1177\/0961203315591027","volume":"24","author":"M Leroux","year":"2015","unstructured":"Leroux M, Desveaux C, Parcevaux M et al (2015) Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study. Lupus 24:1384\u20131391. https:\/\/doi.org\/10.1177\/0961203315591027","journal-title":"Lupus"},{"key":"6496_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1191\/096120301678646137","volume":"10","author":"RA Levy","year":"2001","unstructured":"Levy RA, Vilela VS, Cataldo MJ et al (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10:401\u2013404. https:\/\/doi.org\/10.1191\/096120301678646137","journal-title":"Lupus"},{"key":"6496_CR10","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical Research Ed) 339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ (Clinical Research Ed)"},{"key":"6496_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"6496_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383\u2013394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","journal-title":"J Clin Epidemiol"},{"key":"6496_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"6496_CR14","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719\u2013748","journal-title":"J Natl Cancer Inst"},{"key":"6496_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"6496_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW (2010) Outlier and influence diagnostics for meta-analysis. Res Synth Methods 1:112\u2013125. https:\/\/doi.org\/10.1002\/jrsm.11","journal-title":"Res Synth Methods"},{"key":"6496_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/jrsm.1053","volume":"3","author":"I Olkin","year":"2012","unstructured":"Olkin I, Dahabreh IJ, Trikalinos TA (2012) GOSH - a graphical display of study heterogeneity. Res Synth Methods 3:214\u2013223. https:\/\/doi.org\/10.1002\/jrsm.1053","journal-title":"Res Synth Methods"},{"key":"6496_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed) 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ (Clinical Research Ed)"},{"key":"6496_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"6496_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed) 315:629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ (Clinical Research Ed)"},{"key":"6496_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","volume":"14","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Lazzaroni MG, Kuzenko A et al (2015) The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study. Autoimmun Rev 14:498\u2013502. https:\/\/doi.org\/10.1016\/j.autrev.2015.01.012","journal-title":"Autoimmun Rev"},{"key":"6496_CR22","doi-asserted-by":"publisher","unstructured":"Sciascia S, Hunt BJ, Talavera-Garcia E, Lliso G, Khamashta MA, Cuadrado MJ (2016) The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecology 214:273e271\u2013273e278. https:\/\/doi.org\/10.1016\/j.ajog.2015.09.078","DOI":"10.1016\/j.ajog.2015.09.078"},{"key":"6496_CR23","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1177\/0961203320952850","volume":"29","author":"JO Latino","year":"2020","unstructured":"Latino JO, Udry S, Aranda F et al (2020) Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine. Lupus 29:1736\u20131742. https:\/\/doi.org\/10.1177\/0961203320952850","journal-title":"Lupus"},{"key":"6496_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.thromres.2021.08.004","volume":"206","author":"M Gerde","year":"2021","unstructured":"Gerde M, Ibarra E, Mac Kenzie R et al (2021) The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thromb Res 206:104\u2013110. https:\/\/doi.org\/10.1016\/j.thromres.2021.08.004","journal-title":"Thromb Res"},{"key":"6496_CR25","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/art.11304","volume":"48","author":"N Costedoat-Chalumeau","year":"2003","unstructured":"Costedoat-Chalumeau N, Amoura Z, Duhaut P et al (2003) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48:3207\u20133211. https:\/\/doi.org\/10.1002\/art.11304","journal-title":"Arthritis Rheum"},{"key":"6496_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","volume":"39","author":"O Diav-Citrin","year":"2013","unstructured":"Diav-Citrin O, Blyakhman S, Shechtman S, Ornoy A (2013) Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. Reprod Toxicol 39:58\u201362. https:\/\/doi.org\/10.1016\/j.reprotox.2013.04.005","journal-title":"Reprod Toxicol"},{"key":"6496_CR27","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/rheumatology\/keaa592","volume":"60","author":"NW Andersson","year":"2021","unstructured":"Andersson NW, Skov L, Andersen JT (2021) Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. Rheumatology (United Kingdom) 60:2317\u20132326. https:\/\/doi.org\/10.1093\/rheumatology\/keaa592","journal-title":"Rheumatology (United Kingdom)"},{"key":"6496_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/jog.14561","volume":"47","author":"MS Beksac","year":"2021","unstructured":"Beksac MS, Donmez HG (2021) Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug. J Obstet Gynaecol Res 47:570\u2013575. https:\/\/doi.org\/10.1111\/jog.14561","journal-title":"J Obstet Gynaecol Res"},{"key":"6496_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/art.42015","volume":"74","author":"CD Chambers","year":"2022","unstructured":"Chambers CD, Johnson DL, Xu R et al (2022) Birth outcomes in women who have taken hydroxycholoroquine in pregnancy: a prospective cohort study. Arthritis Rheumatol 74:711\u2013724. https:\/\/doi.org\/10.1002\/art.42015","journal-title":"Arthritis Rheumatol"},{"key":"6496_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/nep.13991","volume":"27","author":"C Tang","year":"2022","unstructured":"Tang C, Si FL, Yao YX et al (2022) The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: a retrospective cohort study. Nephrology (Carlton) 27:155\u2013161. https:\/\/doi.org\/10.1111\/nep.13991","journal-title":"Nephrology (Carlton)"},{"key":"6496_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/ard.55.7.486","volume":"55","author":"NMM Buchanan","year":"1996","unstructured":"Buchanan NMM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GRV (1996) Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 55:486\u2013488. https:\/\/doi.org\/10.1136\/ard.55.7.486","journal-title":"Ann Rheum Dis"},{"key":"6496_CR32","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1002\/art.22159","volume":"54","author":"MEB Clowse","year":"2006","unstructured":"Clowse MEB, Magder L, Witter F, Petri M (2006) Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54:3640\u20133647. https:\/\/doi.org\/10.1002\/art.22159","journal-title":"Arthritis Rheum"},{"key":"6496_CR33","doi-asserted-by":"publisher","first-page":"S273","DOI":"10.1016\/j.ajog.2014.10.594","volume":"212","author":"S Baalbaki","year":"2015","unstructured":"Baalbaki S, Subramaniam A, Szychowski J, Tang Y, Wetta L (2015) Systemic lupus erythematosus: outcomes in women treated with and without hydroxychloroquine. Am J Obstet Gynecol 212:S273\u2013S274. https:\/\/doi.org\/10.1016\/j.ajog.2014.10.594","journal-title":"Am J Obstet Gynecol"},{"key":"6496_CR34","doi-asserted-by":"publisher","first-page":"2810202","DOI":"10.1155\/2017\/2810202","volume":"2017","author":"SJ Kroese","year":"2017","unstructured":"Kroese SJ, De Hair MJH, Limper M et al (2017) Hydroxychloroquine use in lupus patients during pregnancy is associated with longer pregnancy duration in premature deliverys. J Immunol Res 2017:2810202. https:\/\/doi.org\/10.1155\/2017\/2810202","journal-title":"J Immunol Res"},{"key":"6496_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1055\/s-0040-1715140","volume":"42","author":"R Abd Rahman","year":"2020","unstructured":"Abd Rahman R, Min Tun K, KamisanAtan I, Mohamed Said MS, Mustafar R, Zainuddin AA (2020) New Benefits of hydroxychloroquine in pregnant women with systemic lupus erythematosus: a retrospective study in a tertiary centre. Rev Bras Ginecol Obstet 42:705\u2013711. https:\/\/doi.org\/10.1055\/s-0040-1715140","journal-title":"Rev Bras Ginecol Obstet"},{"key":"6496_CR36","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1055\/s-0039-3402752","volume":"37","author":"SC Do","year":"2020","unstructured":"Do SC, Rizk NM, Druzin ML, Simard JF (2020) Does hydroxychloroquine protect against preeclampsia and preterm delivery in systemic lupus erythematosus pregnancies? Am J Perinatol 37:873\u2013880. https:\/\/doi.org\/10.1055\/s-0039-3402752","journal-title":"Am J Perinatol"},{"key":"6496_CR37","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1002\/art.41538","volume":"72","author":"I Haase","year":"2020","unstructured":"Haase I, Schneider M, Brinks R, Fischer-Betz R (2020) Safety and beneficial effects of hydroxychloroquine on pregnancy outcomes in women with systemic lupus erythematosus. Arthritis Rheum 72:3578\u20133579. https:\/\/doi.org\/10.1002\/art.41538","journal-title":"Arthritis Rheum"},{"key":"6496_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/25785826.2020.1868652","volume":"44","author":"V Canti","year":"2021","unstructured":"Canti V, Scarrone M, De Lorenzo R et al (2021) Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine. Immunol Med 44:204\u2013210. https:\/\/doi.org\/10.1080\/25785826.2020.1868652","journal-title":"Immunol Med"},{"key":"6496_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00404-020-05762-5","volume":"303","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang Y, Wei Y, Yang H (2021) Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis. Arch Gynecol Obstet 303:435\u2013441. https:\/\/doi.org\/10.1007\/s00404-020-05762-5","journal-title":"Arch Gynecol Obstet"},{"key":"6496_CR40","doi-asserted-by":"publisher","first-page":"e24553","DOI":"10.1097\/MD.0000000000024553","volume":"100","author":"W Louthrenoo","year":"2021","unstructured":"Louthrenoo W, Trongkamolthum T, Kasitanon N, Wongthanee A (2021) Predicting factors of adverse pregnancy outcomes in Thai patients with systemic lupus erythematosus: A STROBE-compliant study. Medicine 100:e24553. https:\/\/doi.org\/10.1097\/MD.0000000000024553","journal-title":"Medicine"},{"key":"6496_CR41","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF (2006) WHO analysis of causes of maternal death: a systematic review. Lancet (London, England) 367:1066\u20131074. https:\/\/doi.org\/10.1016\/S0140-6736(06)68397-9","journal-title":"Lancet (London, England)"},{"key":"6496_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y et al (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116:402\u2013414. https:\/\/doi.org\/10.1097\/AOG.0b013e3181e9322a","journal-title":"Obstet Gynecol"},{"key":"6496_CR43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76:476\u2013485. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"},{"key":"6496_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1028-4559(09)60224-2","volume":"45","author":"TH Hung","year":"2006","unstructured":"Hung TH, Burton GJ (2006) Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 45:189\u2013200. https:\/\/doi.org\/10.1016\/S1028-4559(09)60224-2","journal-title":"Taiwan J Obstet Gynecol"},{"key":"6496_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1677\/JOE-06-0061","volume":"192","author":"S Mandang","year":"2007","unstructured":"Mandang S, Manuelpillai U, Wallace EM (2007) Oxidative stress increases placental and endothelial cell activin A secretion. J Endocrinol 192:485\u2013493. https:\/\/doi.org\/10.1677\/JOE-06-0061","journal-title":"J Endocrinol"},{"key":"6496_CR46","doi-asserted-by":"publisher","first-page":"R736","DOI":"10.1152\/ajpregu.00168.2006","volume":"292","author":"MJ Ryan","year":"2007","unstructured":"Ryan MJ, McLemore GR Jr (2007) Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol 292:R736-742. https:\/\/doi.org\/10.1152\/ajpregu.00168.2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"6496_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.preghy.2016.09.001","volume":"6","author":"R Rahman","year":"2016","unstructured":"Rahman R, Murthi P, Singh H et al (2016) The effects of hydroxychloroquine on endothelial dysfunction. Pregnancy Hypertens 6:259\u2013262. https:\/\/doi.org\/10.1016\/j.preghy.2016.09.001","journal-title":"Pregnancy Hypertens"},{"key":"6496_CR48","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/pd.5709","volume":"40","author":"MA Limaye","year":"2020","unstructured":"Limaye MA, Buyon JP, Cuneo BF, Mehta-Lee SS (2020) A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenat Diagn 40:1066\u20131076. https:\/\/doi.org\/10.1002\/pd.5709","journal-title":"Prenat Diagn"},{"key":"6496_CR49","doi-asserted-by":"publisher","unstructured":"Garner P, G\u00fclmezoglu AM (2006) Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev:Cd000169. https:\/\/doi.org\/10.1002\/14651858.CD000169.pub2","DOI":"10.1002\/14651858.CD000169.pub2"},{"key":"6496_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2515\/therapie\/2013003","volume":"68","author":"N Tarfaoui","year":"2013","unstructured":"Tarfaoui N, Autret-Leca E, Mazjoub S, Cissoko H, Jonville-Bera AP (2013) Hydroxychloroquine during pregnancy: a review of retinal toxicity in the newborns. Therapie 68:43\u201347. https:\/\/doi.org\/10.2515\/therapie\/2013003","journal-title":"Therapie"},{"key":"6496_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1546-0096-7-9","volume":"7","author":"K Sperber","year":"2009","unstructured":"Sperber K, Hom C, Chao CP, Shapiro D, Ash J (2009) Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J 7:9. https:\/\/doi.org\/10.1186\/1546-0096-7-9","journal-title":"Pediatr Rheumatol Online J"},{"key":"6496_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","volume":"4","author":"N Costedoat-Chalumeau","year":"2005","unstructured":"Costedoat-Chalumeau N, Amoura Z, Huong DL, Lechat P, Piette JC (2005) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 4:111\u2013115. https:\/\/doi.org\/10.1016\/j.autrev.2004.11.009","journal-title":"Autoimmun Rev"},{"key":"6496_CR53","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/09612033211007199","volume":"30","author":"J Duan","year":"2021","unstructured":"Duan J, Ma D, Wen X et al (2021) Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis. Lupus 30:1163\u20131174. https:\/\/doi.org\/10.1177\/09612033211007199","journal-title":"Lupus"},{"key":"6496_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.ajkd.2019.01.026","volume":"74","author":"LJ Liu","year":"2019","unstructured":"Liu LJ, Yang YZ, Shi SF et al (2019) Effects of Hydroxychloroquine on proteinuria in IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 74:15\u201322. https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.026","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06496-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T06:18:38Z","timestamp":1681366718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06496-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6496"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06496-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}